Covista (CVSA)
NYSE:CVSA
CVSA Stock Chart & Stats
$118.00
-$0.04(-0.04%)
At close: 4:00 PM EST
$118.00
-$0.04(-0.04%)
Day’s Range― - ―
52-Week Range$86.97 - $156.26
Previous CloseN/A
VolumeN/A
Average Volume (3M)372.76K
Market Cap
$4.07B
Enterprise Value$4.75B
Total Cash (Recent Filing)$56.28M
Total Debt (Recent Filing)$729.55M
Price to Earnings (P/E)12.3
Beta0.70
Next Earnings
May 07, 2026EPS Estimate
1.72Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.43
Shares Outstanding34,508,522
10 Day Avg. Volume261,256
30 Day Avg. Volume372,759
Financial Highlights & Ratios
PEG Ratio0.25
Price to Book (P/B)3.29
Price to Sales (P/S)2.64
P/FCF Ratio16.41
Enterprise Value/Market Cap1.17
Enterprise Value/Revenue2.51
Enterprise Value/Gross Profit4.38
Enterprise Value/Ebitda11.06
Forecast
1Y Price Target
$153.75Price Target Upside30.30% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)7.94
Revenue Forecast (FY)$1.92B
Bulls Say, Bears Say
Bulls Say
AI-enabled Student Lifecycle ImprovementsDeployment of AI across enrollment, predictive analytics, micro-grants, and an AI tutor could improve student persistence and course completion, supporting stronger program outcomes and revenue per student.
Financing And Employer IntegrationExisting financing partnerships for medical and veterinary programs, combined with plans for contracted employer pipelines, could reduce barriers to enrollment and enhance placement outcomes, supporting demand.
Growth Strategy ExecutionPurpose at Scale strategy aims to expand campus footprint and launch new healthcare-focused courses, which could attract more students and drive revenue expansion.
Bears Say
Aggressive Investment Risk ProfileAnalyst classifies the company's investment profile as aggressive, implying greater share price volatility and elevated downside risk for investors.
Brand-level Enrollment WeaknessesEnrollment funnel issues and slowing post-licensure nursing enrollments at the Chamberlain brand could weigh on revenue growth and pressure segment margins.
Guidance Signals Top-line HeadwindManagement guidance that contemplates top-line softness at Chamberlain signals a potential headwind to company-wide growth expectations and could dampen investor sentiment.
Covista News
CVSA FAQ
What was Covista’s price range in the past 12 months?
Covista lowest stock price was $86.97 and its highest was $156.26 in the past 12 months.
What is Covista’s market cap?
Covista’s market cap is $4.07B.
When is Covista’s upcoming earnings report date?
Covista’s upcoming earnings report date is May 07, 2026 which is in 28 days.
How were Covista’s earnings last quarter?
Covista released its earnings results on Jan 28, 2026. The company reported $2.43 earnings per share for the quarter, beating the consensus estimate of $2.188 by $0.242.
Is Covista overvalued?
According to Wall Street analysts Covista’s price is currently Undervalued.
Does Covista pay dividends?
Covista pays a Semiannually dividend of $0.18 which represents an annual dividend yield of N/A. See more information on Covista dividends here
What is Covista’s EPS estimate?
Covista’s EPS estimate is 1.72.
How many shares outstanding does Covista have?
Covista has 34,508,522 shares outstanding.
What happened to Covista’s price movement after its last earnings report?
Covista reported an EPS of $2.43 in its last earnings report, beating expectations of $2.188. Following the earnings report the stock price went down -7.022%.
Which hedge fund is a major shareholder of Covista?
Currently, no hedge funds are holding shares in CVSA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Covista Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$153.75 (30.30% Upside)
$153.75 (30.30% Upside)
Blogger Sentiment
Bullish
CVSA Sentiment 80%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 307.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $3.8M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.8%
Last 30 Days ▼ 2.1%
Last 30 Days ▼ 2.1%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
19.56%
12-Months-Change
Fundamentals
Return on Equity
17.76%
Trailing 12-Months
Asset Growth
-3.98%
Trailing 12-Months
Company Description
Covista
Adtalem Global Education, Inc. engages in the provision of post-secondary education. It operates through the following segments: Chamberlain, Walden, and Medical and Veterinary. The Chamberlain segment offers degree and non-degree programs in the nursing and health professions postsecondary education industry. The Walden segment covers online certificates, bachelor's, master's, and doctoral degrees, including those in nursing, education, counseling, business, psychology, public health, social work and human services, public administration and public policy, and criminal justice. The Medical and Veterinary segment includes degree and non-degree programs in the medical and veterinary postsecondary education industry. The company was founded by Dennis J. Keller and Ronald L. Taylor in 1973 and is headquartered in Chicago, IL.
CVSA Company Deck
CVSA Earnings Call
Q2 2026
0:00 / 0:00
CVSA Stock 12 Month Forecast
Average Price Target
$153.75
▲(30.30% Upside)
Technical Analysis
Perdoceo Education
―
Grand Canyon Education
―
Strategic Education
―
Graham Holdings
―
Laureate Education
―
Ownership Overview
2.83% Insiders
37.98% Mutual Funds
22.09% Other Institutional Investors
9.00% Public Companies and
Individual Investors